The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Neuropsychiatric symptoms in Parkinson's disease
Open accessAbstract
Neuropsychiatric symptoms are common in Parkinson's disease, even at the earliest stages, and have important consequences for quality of life and daily functioning, are associated with increased carer burden and increased risk for nursing home admission. In addition to cognitive impairment, a wide range of neuropsychiatric symptoms have been reported. In this article, the epidemiology, clinical course, diagnosis, and management of some of the most common neuropsychiatric symptoms in PD are discussed: depression, anxiety, apathy, fatigue, and psychotic symptoms. Although much is known regarding the prevalence and course of these symptoms, the empirical evidence for how to manage these symptoms is limited at best. There is thus an urgent need for systematic studies for the pharmacological and non‐pharmacological management of these symptoms. © 2009 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,117
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
A systematic review of prevalence studies of dementia in Parkinson's disease
Aarsland, D., Zaccai, J., & Brayne, C. (2005) · Movement Disorders · doi:10.1002/mds.20527 · Cited by 1,689
Self-citationPrevalence and Characteristics of Dementia in Parkinson Disease: An 8-Year Prospective Study
Aarsland, D., Andersen, K., Larsen, J. P., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,401
Self-citationA systematic review of prevalence studies of depression in Parkinson's disease
Reijnders, J. S. A. M., Ehrt, U., Weber, W. E. J., Aarsland, D., & Leentjens, A. F. G. (2008) · Movement Disorders · doi:10.1002/mds.21803 · Cited by 1,239
Self-citationRivastigmine for Dementia Associated with Parkinson's Disease
Emre, M., Aarsland, D., Albanese, A., Byrne, E. J., Deuschl, G., De Deyn, P. P., Durif, F., Kulisevsky, J., van Laar, T., Lees, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041470 · Cited by 1,223
Self-citationReliability, validity, and clinical correlates of apathy in Parkinson's disease
(1992) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.4.2.134 · Cited by 1,185
Remy, P., Doder, M., Lees, A., Turjanski, N., & Brooks, D. (2005) · Brain · doi:10.1093/brain/awh445 · Cited by 1,040
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
Fenelon, G. (2000) · Brain · doi:10.1093/brain/123.4.733 · Cited by 1,037
Cited by
Priorities in Parkinson's disease research
Meissner, W. G., Frasier, M., Gasser, T., Goetz, C. G., Lozano, A., Piccini, P., Obeso, J. A., Rascol, O., Schapira, A., Voon, V., et al. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3430 · Cited by 436
Mhyre, T. R., Boyd, J. T., Hamill, R. W., & Maguire-Zeiss, K. A. (2012) · Subcellular Biochemistry · doi:10.1007/978-94-007-5416-4_16 · Cited by 423
Depression and Parkinson’s Disease: Current Knowledge
Marsh, L. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0409-5 · Cited by 404
Self-citationThe anatomy of apathy: a neurocognitive framework for amotivated behaviour
Le Heron, C., Apps., M. A. J., & Husain, M. (2018) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2017.07.003 · Cited by 380
“Apathy is common at all stages of the disease, is associated with impaired quality of life for both patients and their relatives, and is a presenting symptom in a significant number of cases (Aarsland et al., 2009).”
BackgroundAdult Neurogenesis in Neurodegenerative Diseases: Figure 1.
Winner, B., & Winkler, J. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021287 · Cited by 305
Subthalamic stimulation in Parkinson’s disease: restoring the balance of motivated behaviours
Lhommée, E., Klinger, H., Thobois, S., Schmitt, E., Ardouin, C., Bichon, A., Kistner, A., Fraix, V., Xie, J., Aya Kombo, M., et al. (2012) · Brain · doi:10.1093/brain/aws078 · Cited by 296
Maillet, A., Krack, P., Lhommée, E., Météreau, E., Klinger, H., Favre, E., Le Bars, D., Schmitt, E., Bichon, A., Pelissier, P., et al. (2016) · Brain · doi:10.1093/brain/aww162 · Cited by 282
Lindqvist, D., Hall, S., Surova, Y., Nielsen, H. M., Janelidze, S., Brundin, L., & Hansson, O. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.07.007 · Cited by 276
Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil
Thobois, S., Lhommée, E., Klinger, H., Ardouin, C., Schmitt, E., Bichon, A., Kistner, A., Castrioto, A., Xie, J., Fraix, V., et al. (2013) · Brain · doi:10.1093/brain/awt067 · Cited by 274
The Neuropsychiatric Inventory: Development and Applications
Cummings, J. (2020) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988719882102 · Cited by 259
Lindqvist, D., Kaufman, E., Brundin, L., Hall, S., Surova, Y., & Hansson, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047387 · Cited by 236
Stress, depression and Parkinson's disease
Hemmerle, A. M., Herman, J. P., & Seroogy, K. B. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.035 · Cited by 225
Neuropsychiatric symptoms and caregiver's burden in Parkinson's disease
Martinez-Martin, P., Rodriguez-Blazquez, C., Forjaz, M. J., Frades-Payo, B., Agüera-Ortiz, L., Weintraub, D., Riesco, A., Kurtis, M. M., & Chaudhuri, K. R. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.03.024 · Cited by 222
The importance of non-motor disturbances to quality of life in Parkinson's disease
Martinez-Martin, P. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.05.006 · Cited by 160
O'Callaghan, C., Bertoux, M., & Hornberger, M. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304558 · Cited by 131
Nakum, S., & Cavanna, A. E. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.02.017 · Cited by 70
Wuthrich, V. M., & Rapee, R. M. (2019) · Clinical Gerontologist · doi:10.1080/07317115.2019.1580811 · Cited by 52
Cognitive Behavioral Therapy for Depression and Anxiety in Parkinson's Disease: A Clinical Review
Armento, M. E. A., Stanley, M. A., Marsh, L., Kunik, M. E., York, M. K., Bush, A. L., & Calleo, J. S. (2012) · Journal of Parkinson's Disease · doi:10.3233/jpd-2012-12080 · Cited by 49
Self-citationApathy is associated with activities of daily living ability in Parkinson's disease
Laatu, S., Karrasch, M., Martikainen, K., & Marttila, R. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000347129 · Cited by 37
Anhedonia and its correlation with clinical aspects in Parkinson’s disease
Nagayama, H., Maeda, T., Uchiyama, T., Hashimoto, M., Nomoto, N., Kano, O., Takahashi, T., Terashi, H., Hamada, S., Hasegawa, T., et al. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.10.051 · Cited by 33
“Pseudo-syndromes” associated with Parkinson disease, dementia, apathy, anxiety, and depression
Weiss, H. D., & Pontone, G. M. (2019) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000644 · Cited by 21
Hedonic Deficits in Parkinson’s Disease: Is Consummatory Anhedonia Specific?
Loas, G., Duru, C., Godefroy, O., & Krystkowiak, P. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00024 · Cited by 18
Metadata
- Authors
- Aarsland, D., Marsh, L., & Schrag, A.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2009-09-18
- Volume
- 24
- Issue
- 15
- Pages
- 2175-2186
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2101206139
- Cited by
- 557
- References
- 121
- FWCI
- 16.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.